Publication
Colite pseudomembranosa : uma casuística de internamentos
| dc.contributor.author | Almeida, N | |
| dc.contributor.author | Silva, N | |
| dc.contributor.author | Parente, F | |
| dc.contributor.author | Portela, F | |
| dc.contributor.author | Gouveia, H | |
| dc.contributor.author | Alexandrino, MB | |
| dc.contributor.author | Alves-Moura, JJ | |
| dc.contributor.author | Freitas, D | |
| dc.date.accessioned | 2011-11-17T18:46:58Z | |
| dc.date.available | 2011-11-17T18:46:58Z | |
| dc.date.issued | 2006 | |
| dc.description.abstract | Introduction: pseudomembranous colitis (PMC) is an infectious disease that generally begins after antibiotic treatment. Objectives: Characterize the patients with PMC in two Services of a Central Hospital. Material and Methods: we considered the patients admitted in a Medicine (MS) and in a Gastroenterology (GES) Service with primary or secondary diagnosis of PMC, between January/1995 and July/2003 and registered the age, gender, clinical presentation, antibiotics (AB) and other risk factors, diagnostic procedures, complications and treatment. Results: we considered 80 patients (43 - GES and 37 - MS); Mean age - 68,6 ± 17,7 years; 52,5% were male; Antibiotic treatment in the previous 3 months - 85%; Mean time of antibiotic treatment - 10,5 ± 6,1 days. Most Commonly Involved Antibiotics: cephalosporins, amoxicillin/clavulanic acid and quinolones. Associated risk factors: renal insufficiency (22,5%); cardiac insufficiency (22,5%); previously dependent patient ( 36,3%). Diagnostic procedures: toxin search-58 patients ( in 36 ), colonoscopy - 62 ( in 53); culture - 23 (in 17 ). The mortality rate was 18,8% (n = 15); recurrence rate - 10% (n = 8). Therapeutics: metronidazol - 37 patients (46,3%); vancomycin - 24 (30%); metronidazol + vancomycin – 12 (15%). Differences Between Services: mean age (MS - 72,9 and GES - 64,9); admission criteria (GES - intestinal disorders, MS – respiratory infections); diagnostic procedures (colonoscopy more frequent in GES); therapeutic options (MS - metronidazol; GES - vancomycin and metronidazol + vancomycin). Conclusions: PMC is more common in older patients that were generally submitted to previous antibiotic treatment, especially with ß-lactamics. Considering two distinct Services we observed differences concerning age, co-morbility and risk factors that implied distinct diagnostic and therapeutic approaches. | por |
| dc.identifier.citation | J Port Gastrenterol. 2006; 13 (1): 6-13 | por |
| dc.identifier.uri | http://hdl.handle.net/10400.4/1162 | |
| dc.language.iso | por | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Sociedade Portuguesa de Gastrenterologia | por |
| dc.subject | Colite Pseudomembranosa | por |
| dc.title | Colite pseudomembranosa : uma casuística de internamentos | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess | por |
| rcaap.type | article | por |